Related references
Note: Only part of the references are listed.The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
Yan-Rong Guo et al.
MILITARY MEDICAL RESEARCH (2020)
Incorporation of ORF2 from Porcine Circovirus Type 2(PCV2) into genetically encoded nanoparticles as a novel vaccine using a self-aggregating peptide
Jesus Zepeda-Cervantes et al.
VACCINE (2019)
A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates
Sung-Youl Ko et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses
James D. Allen et al.
JOURNAL OF VIROLOGY (2019)
Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen
Andrew G. Diamos et al.
VACCINE (2019)
Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins
Marianela C. Serradell et al.
NATURE COMMUNICATIONS (2019)
Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses
Katrin Kramer et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Virus-based pharmaceutical production in plants: an opportunity to reduce health problems in Africa
Pingdwende Kader Aziz Bamogo et al.
VIROLOGY JOURNAL (2019)
Modulation of TAP-dependent antigen compartmentalization during human monocyte-to-DC differentiation
Marius Doering et al.
BLOOD ADVANCES (2019)
TLR agonist combinations that stimulate Th type I polarizing responses from human neonates
Naveen Surendran et al.
INNATE IMMUNITY (2018)
Glycosylation of Hemagglutinin and Neuraminidase of Influenza A Virus as Signature for Ecological Spillover and Adaptation among Influenza Reservoirs
Paul Kim et al.
VIRUSES-BASEL (2018)
Dengue envelope-based 'four-in-one' virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice
Ravi Kant Rajpoot et al.
SCIENTIFIC REPORTS (2018)
Zika virus like particles elicit protective antibodies in mice
Mauricio A. Salvo et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice
Viswanathan Ramasamy et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Langerhans Cells: Sensing the environment in Health and Disease
Julie Deckers et al.
FRONTIERS IN IMMUNOLOGY (2018)
A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system
Joshua Pankrac et al.
NPJ VACCINES (2018)
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Shiyu Dai et al.
VIROLOGICA SINICA (2018)
Induction of adaptive immune response by self-aggregating peptides
Jesus Zepeda-Cervantes et al.
EXPERT REVIEW OF VACCINES (2018)
Virus-Like Particles as Carrier Systems to Enhance Immunomodulation in Allergen Immunotherapy
Martina Anzaghe et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2018)
Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells
Yohei Otsuka et al.
JOURNAL OF IMMUNOLOGY (2018)
Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature
Helene Boigard et al.
VACCINE (2018)
Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
Ludger Klimek et al.
ALLERGO JOURNAL (2018)
Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells
P. Engeroff et al.
ALLERGY (2018)
Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α
Federica Sallusto et al.
JOURNAL OF IMMUNOLOGY (2018)
Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris Are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies
Niyati Khetarpal et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination
Mona O. Mohsen et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus
Himanshu Garg et al.
JOURNAL OF VIROLOGY (2017)
Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice
Jorma Hinkula et al.
JOURNAL OF VIROLOGY (2017)
Major findings and recent advances in virus like particle (VLP)-based vaccines
Mona O. Mohsen et al.
SEMINARS IN IMMUNOLOGY (2017)
Zika virus-like particle (VLP) based vaccine
Helene Boigard et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models
Aura R. Garrison et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Virus like particles as a platform for cancer vaccine development
Hui Kian Ong et al.
PEERJ (2017)
Natural IgM and TLR Agonists Switch Murine Splenic Pan-B to Regulatory Cells That Supress Ischemia-Induced Innate Inflammation via Regulating NKT-1 Cells
Peter I. Lobo et al.
FRONTIERS IN IMMUNOLOGY (2017)
Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice
Yu-Jin Kim et al.
FRONTIERS IN IMMUNOLOGY (2017)
Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000
Farah Huzair et al.
STUDIES IN HISTORY AND PHILOSOPHY OF SCIENCE PART C-STUDIES IN HISTORY AND PHILOSOPHY OF BIOLOGICAL AND BIOMEDICAL SCIENCES (2017)
Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus
Akane Urakami et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Efficacy of Human Papillomavirus L1 Protein Vaccines (Cervarix and Gardasil) in Reducing the Risk of Cervical Intraepithelial Neoplasia: A Meta-analysis
Mohammad Reza Haghshenas et al.
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE (2017)
Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies
Ankur Poddar et al.
BMC BIOTECHNOLOGY (2016)
Actin' on HIV: How Dendritic Cells Spread Infection
Daniel A. Donahue et al.
CELL HOST & MICROBE (2016)
Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody
Lianpan Dai et al.
CELL HOST & MICROBE (2016)
Protective and immunological behavior of chimeric yellow fever dengue vaccine
Scott B. Halstead et al.
VACCINE (2016)
pH-responsive Virus-like Nanoparticles with Enhanced Tumour-targeting Ligands for Cancer Drug Delivery
Roya Biabanikhankahdani et al.
SCIENTIFIC REPORTS (2016)
Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus
Ryohei Saga et al.
SCIENTIFIC REPORTS (2016)
Emerging Functions of Natural IgM and Its Fc Receptor FCMR in Immune Homeostasis
Hongsheng Wang et al.
FRONTIERS IN IMMUNOLOGY (2016)
Influenza Virus-Like Particles Engineered by Protein Transfer With Tumor-Associated Antigens Induces Protective Antitumor Immunity
Jaina M. Patel et al.
BIOTECHNOLOGY AND BIOENGINEERING (2015)
Myeloid dendritic cells: Development, functions, and role in atherosclerotic inflammation
Dimitry A. Chistiakov et al.
IMMUNOBIOLOGY (2015)
The role of Fc-FcγR interactions in IgG-mediated microbial neutralization
Stylianos Bournazos et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Glycoprotein E of the Japanese encephalitis virus forms virus-like particles and induces syncytia when expressed by a baculovirus
Ruikun Du et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Antigen presentation kinetics control T cell/dendritic cell interactions and follicular helper T cell generation in vivo
Robert A. Benson et al.
ELIFE (2015)
Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies
Lav Tripathi et al.
FRONTIERS IN MICROBIOLOGY (2015)
Recent Advances of Vaccine Adjuvants for Infectious Diseases
Sujin Lee et al.
IMMUNE NETWORK (2015)
Natural IgM Is Produced by CD5- Plasma Cells That Occupy a Distinct Survival Niche in Bone Marrow
Alexander E. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2015)
Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation
Emilie Seydoux et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Immunogenicity of therapeutic proteins: Influence of aggregation
Kirsty D. Ratanji et al.
JOURNAL OF IMMUNOTOXICOLOGY (2014)
Type I and type II Fc receptors regulate innate and adaptive immunity
Andrew Pincetic et al.
NATURE IMMUNOLOGY (2014)
An Engineered Non-Toxic Superantigen Increases Cross Presentation of Hepatitis B Virus Nucleocapsids by Human Dendritic Cells
Julie D. McIntosh et al.
PLOS ONE (2014)
Mannosylation of Virus-Like Particles Enhances Internalization by Antigen Presenting Cells
Farah Al-Barwani et al.
PLOS ONE (2014)
Anaphylaxis after vaccination of children: Review of literature and recommendations for vaccination in child and school health services in Belgium
Anouk Vanlander et al.
VACCINE (2014)
Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity
Michael A. Schmid et al.
FRONTIERS IN IMMUNOLOGY (2014)
Size-Dependent Uptake of Particles by Pulmonary Antigen-Presenting Cell Populations and Trafficking to Regional Lymph Nodes
Fabian Blank et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Pathways of Antigen Processing
Janice S. Blum et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma
Kai-Michael Beeh et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Antigen Incorporated In Virus-like Particles Is Delivered to Specific Dendritic Cell Subsets That Induce An Effective Antitumor Immune Response In Vivo
Kunyu Li et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Construction and Characterization of Virus-Like Particles: A Review
Andris Zeltins
MOLECULAR BIOTECHNOLOGY (2013)
An Enhanced Heterologous Virus-Like Particle for Human Papillomavirus Type 16 Tumour Immunotherapy
Khairunadwa Jemon et al.
PLOS ONE (2013)
Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
Shailendra Mani et al.
PLOS ONE (2013)
Direct Activation of Human Dendritic Cells by Particle-Bound but Not Soluble MHC Class II Ligand
Renato B. Baleeiro et al.
PLOS ONE (2013)
Presentation of Phagocytosed Antigens by MHC Class I and II
Adriana R. Mantegazza et al.
TRAFFIC (2013)
Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
Stefan Nierkens et al.
TRENDS IN IMMUNOLOGY (2013)
Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice
Upasana Arora et al.
VACCINE (2013)
Effective Chikungunya Virus-like Particle Vaccine Produced in Insect Cells
Stefan W. Metz et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Revisiting the Role of Glycosylation in the Structure of Human IgG Fc
M. Jack Borrok et al.
ACS CHEMICAL BIOLOGY (2012)
Novel roles for the IgG Fc glycan
Robert M. Anthony et al.
GLYCOBIOLOGY OF THE IMMUNE RESPONSE (2012)
Poly-γ-Glutamic Acid Nanoparticles and Aluminum Adjuvant Used as an Adjuvant with a Single Dose of Japanese Encephalitis Virus-Like Particles Provide Effective Protection from Japanese Encephalitis Virus
Shigefumi Okamoto et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+ T-cell responses in melanoma patients
Simone M. Goldinger et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Virus-like particles and α-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responses
Sara J. McKee et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages
Ansuman T. Satpathy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen
Alexander Link et al.
JOURNAL OF IMMUNOLOGY (2012)
Hepatitis C VLPs Delivered to Dendritic Cells by a TLR2 Targeting Lipopeptide Results in Enhanced Antibody and Cell-Mediated Responses
Brendon Y. Chua et al.
PLOS ONE (2012)
Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responses
Juliana Bessa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Virus-like particles: potential veterinary vaccine immunogens
Fuxiao Liu et al.
RESEARCH IN VETERINARY SCIENCE (2012)
Mechanisms of Fc Receptor and Dectin-1 Activation for Phagocytosis
Helen S. Goodridge et al.
TRAFFIC (2012)
Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
Natasha Kushnir et al.
VACCINE (2012)
Virus-like particles: The new frontier of vaccines for animal viral infections
Elisa Crisci et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2012)
Commercial porcine circovirus type 2 vaccines: Efficacy and clinical application
Chanhee Chae
VETERINARY JOURNAL (2012)
Virus-like particle (VLP)-based vaccines for pandemic influenza
Constantino López-Macías
Human Vaccines & Immunotherapeutics (2012)
Information processing during phagocytosis
David M. Underhill et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study
L. Klimek et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2011)
Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway
Stephanie J. Win et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors
Sudhanshu Agrawal et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Immunogenicity and Safety of a West Nile Virus Vaccine in Healthy Adults
Rex Biedenbender et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Large-scale production and purification of VLP-based vaccines
Tiago Vicente et al.
JOURNAL OF INVERTEBRATE PATHOLOGY (2011)
Molecular and process design for rotavirus-like particle production in Saccharomyces cerevisiae
William A. Rodriguez-Limas et al.
MICROBIAL CELL FACTORIES (2011)
Murine Polyomavirus Virus-Like Particles Carrying Full-Length Human PSA Protect BALB/c Mice from Outgrowth of a PSA Expressing Tumor
Mathilda Eriksson et al.
PLOS ONE (2011)
A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets
Brendan M. Giles et al.
VACCINE (2011)
Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
Emily M. Plummer et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2011)
Characterization of glycoprotein E C-End of West Nile virus and evaluation of its interaction force with αVβ3 integrin as putative cellular receptor
M. V. Bogachek et al.
BIOCHEMISTRY-MOSCOW (2010)
Transcellular transport of West Nile virus-like particles across human endothelial cells depends on residues 156 and 159 of envelope protein
Rie Hasebe et al.
BMC MICROBIOLOGY (2010)
Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice
Baojing Lu et al.
IMMUNOLOGY (2010)
Cutting Edge: Type I IFN Reverses Human Th2 Commitment and Stability by Suppressing GATA3
Jonathan P. Huber et al.
JOURNAL OF IMMUNOLOGY (2010)
Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients
Daniel E. Speiser et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Assembly and Biological and Immunological Properties of Newcastle Disease Virus-Like Particles
Lori W. McGinnes et al.
JOURNAL OF VIROLOGY (2010)
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection
Wataru Akahata et al.
NATURE MEDICINE (2010)
A self-assembling peptide acting as an immune adjuvant
Jai S. Rudra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection
Subhashini Jagu et al.
VACCINE (2010)
Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice
Chuan Li et al.
VACCINE (2010)
Emergence of a new type of porcine circovirus in swine (PCV): A type 1 and type 2 PCV recombinant
Carl A. Gagnon et al.
VETERINARY MICROBIOLOGY (2010)
被撤回的出版物: A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice (Retracted article. See vol. 232, pg. 266, 2016)
Gunther Spohn et al.
VIROLOGY JOURNAL (2010)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
FluBlok, a next generation influenza vaccine manufactured in insect cells
Manon M. J. Cox et al.
BIOLOGICALS (2009)
Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway
Nuria Izquierdo-Useros et al.
BLOOD (2009)
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial
G. Senti et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Trine H. Mogensen
CLINICAL MICROBIOLOGY REVIEWS (2009)
A Trivalent Virus-Like Particle Vaccine Elicits Protective Immune Responses against Seasonal Influenza Strains in Mice and Ferrets
Ted M. Ross et al.
PLOS ONE (2009)
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Fiona A. Sharp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus
Jonas Naslund et al.
VIROLOGY (2009)
Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant
E. Crisci et al.
VIROLOGY (2009)
Replication cycle of chikungunya: A re-emerging arbovirus
Maxime Solignat et al.
VIROLOGY (2009)
Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses
Matthias Habjan et al.
VIROLOGY (2009)
Chimeric recombinant rotavirus-like particles as a vehicle for the display of heterologous epitopes
Andrea Peralta et al.
VIROLOGY JOURNAL (2009)
Endocytosis of Micro- and Nanosized Particles in vitro by Human Dendritic Cells
P. A. Karalkin et al.
BIOCHEMISTRY MOSCOW SUPPLEMENT SERIES A-MEMBRANE AND CELL BIOLOGY (2009)
Nanoparticles target distinct dendritic cell populations according to their size
Vania Manolova et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like Particles
Y. L. Siu et al.
JOURNAL OF VIROLOGY (2008)
Eastern and Venezuelan Equine Encephalitis Viruses Differ in Their Ability To Infect Dendritic Cells and Macrophages: Impact of Altered Cell Tropism on Pathogenesis
Christina L. Gardner et al.
JOURNAL OF VIROLOGY (2008)
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
A. M. Krieg
ONCOGENE (2008)
Virus-Like Particles of SARS-Like Coronavirus Formed by Membrane Proteins from Different Origins Demonstrate Stimulating Activity in Human Dendritic Cells
Bingke Bai et al.
PLOS ONE (2008)
The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus
Bimmi Shrestha et al.
VACCINE (2008)
A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse
H. El Garch et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2008)
Filovirus-like particles produced in insect cells: Immunogenicity and protection in rodents
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR
Andrea Marzi et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Comparative efficacies of three commercially available Vaccines against west nile virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model
K. K. Seino et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcγ receptors and contributes to acquisition of T cell immunity
Diane M. Da Silva et al.
JOURNAL OF IMMUNOLOGY (2007)
Characterization of reemerging chikungunya virus
Marion Sourisseau et al.
PLOS PATHOGENS (2007)
Virus-like particles-flexible platforms for vaccine development
Bryce Chackerian
EXPERT REVIEW OF VACCINES (2007)
Insect baculoviruses strongly potentiate adaptive immune responses by inducing type IIFN
Sandra Hervas-Stubbs et al.
JOURNAL OF IMMUNOLOGY (2007)
Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand
Tomoki Ito et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Differential antigen processing by dendritic cell subsets in vivo
Diana Dudziak et al.
SCIENCE (2007)
Regulation of memory antibody levels: The role of persisting antigen versus plasma cell life span
Dominique Gatto et al.
JOURNAL OF IMMUNOLOGY (2007)
Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor
Karin Tegerstedt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-β without concomitant T cell responses
Bryce Chackerian et al.
VACCINE (2006)
Virus-like particles: Passport to immune recognition
Elizabeth V. L. Grgacic et al.
METHODS (2006)
Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses
L. Buonaguro et al.
JOURNAL OF VIROLOGY (2006)
Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies
Ling Ye et al.
VIROLOGY (2006)
Pro-oxidative diesel exhaust particle chemicals inhibit LPS-induced dendritic cell responses involved in T-helper differentiation
Ray Chun-Fai Chan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Cutting edge:: Dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice
Cheng-Hu Liu et al.
JOURNAL OF IMMUNOLOGY (2006)
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
Thomas M. Kuendig et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
DM Harper et al.
LANCET (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS)
L DiMiceli et al.
VACCINE (2006)
Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine
AJ García-Piñeres et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Targeting antigens to dendritic cells in vivo
Paul J. Tacken et al.
IMMUNOBIOLOGY (2006)
Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation -: art. no. 45
E Aricò et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Downstream processing of viral vectors and vaccines
R Morenweiser
GENE THERAPY (2005)
A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors
K Tegerstedt et al.
CANCER RESEARCH (2005)
Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals
PY Lozach et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection
WH Kwan et al.
JOURNAL OF VIROLOGY (2005)
Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells
L Bousarghin et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Uptake and presentation of hepatitis C virus-like particles by human dendritic cells
H Barth et al.
BLOOD (2005)
Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells
P Lenz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-κB-mediated signalling, moderated by TGF-β
MY Yan et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects
T Storni et al.
JOURNAL OF IMMUNOLOGY (2004)
Vaccines that facilitate antigen entry into dendritic cells
A Gamvrellis et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Ebola and Marburg virus-like particles activate human myeloid dendritic cells
CM Bosio et al.
VIROLOGY (2004)
Th cell-independent immune responses to chimeric hemagglutinin/simian human immunodeficiency virus-like particles vaccine
QZ Yao et al.
JOURNAL OF IMMUNOLOGY (2004)
Innate sensing of viruses by toll-like receptors
KW Boehme et al.
JOURNAL OF VIROLOGY (2004)
Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis
T Wang et al.
NATURE MEDICINE (2004)
Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells
MY Yan et al.
VIROLOGY (2004)
Plasmacytoid dendritic cells in immunity
M Colonna et al.
NATURE IMMUNOLOGY (2004)
Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice
QY Li et al.
BMC NEUROSCIENCE (2004)
Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells
EA Moseman et al.
JOURNAL OF IMMUNOLOGY (2004)
Ebola virus-like particles protect from lethal Ebola virus infection
KL Warfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells
P Guermonprez et al.
NATURE (2003)
Phagosomes are competent organelles for antigen cross-presentation
M Houde et al.
NATURE (2003)
In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway
VG Morón et al.
JOURNAL OF IMMUNOLOGY (2003)
Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus E protein for a second-generation subunit vaccine
A Kojima et al.
JOURNAL OF VIROLOGY (2003)
Old and new vaccine approaches
R Arnon et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses
E Navarro-Sanchez et al.
EMBO REPORTS (2003)
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells
B Tassaneetrithep et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2
T Compton et al.
JOURNAL OF VIROLOGY (2003)
Impairment of dendritic cells and adaptive immunity by Ebola and lassa viruses
S Mahanty et al.
JOURNAL OF IMMUNOLOGY (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection
F Halary et al.
IMMUNITY (2002)
A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses
A Jegerlehner et al.
VACCINE (2002)
Natural supramolecular building blocks: Wild-type cowpea mosaic virus
Q Wang et al.
CHEMISTRY & BIOLOGY (2002)
Targeting to macrophages:: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages
FL Ahsan et al.
JOURNAL OF CONTROLLED RELEASE (2002)
C-type lectin receptors on dendritic cells and Langerhans cells
CG Figdor et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles
T Watanabe et al.
JOURNAL OF VIROLOGY (2002)
The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells
A Engering et al.
JOURNAL OF IMMUNOLOGY (2002)
Cross-presentation in viral immunity and self-tolerance
WR Heath et al.
NATURE REVIEWS IMMUNOLOGY (2001)
Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies
B Chackerian et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro
MP Rudolf et al.
JOURNAL OF IMMUNOLOGY (2001)
Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells
E Fiebiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
CD8+ but not CD8- dendritic cells cross-prime cytotoxic T cells in vivo
JMM den Haan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
A comparison of two commercial recombinant vaccines for hepatitis B in adolescents
G Leroux-Roels et al.
VACCINE (2000)
Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression
F Sallusto et al.
IMMUNOLOGICAL REVIEWS (2000)
Kinetics of dendritic cell activation:: impact on priming of TH1, TH2 and nonpolarized T cells
A Langenkamp et al.
NATURE IMMUNOLOGY (2000)
Human skin Langerhans cells are targets of dengue virus infection
SJL Wu et al.
NATURE MEDICINE (2000)
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
TBH Geijtenbeek et al.
CELL (2000)
Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules
J Valladeau et al.
IMMUNITY (2000)
Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein
P Nawagitgul et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis
GH MacDonald et al.
JOURNAL OF VIROLOGY (2000)
Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus
LJ Johnston et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Insertion of foreign epitopes in HBcAg: how to make the chimeric particle assemble
LI Karpenko et al.
AMINO ACIDS (2000)
Share Paper
